Trademark Overview
On Monday, February 24, 2025, a trademark application was filed for UNIVERSAL CANCER IMMUNOTHERAPY with the United States Patent and Trademark Office. The USPTO has given the UNIVERSAL CANCER IMMUNOTHERAPY trademark a serial number of 99053458. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, February 24, 2025. This trademark is owned by ImmunityBio, Inc.. The UNIVERSAL CANCER IMMUNOTHERAPY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Biological preparations for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Vaccines; Veterinary pharmaceutical preparations for the prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and cancer; Veterinary pharmaceutical preparations for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, and
cancer